Collaboration to Support Clinical Study of Bryostatin-1 in Leukemia and B-cell Lymphoma
Bryostatin-1 Upregulation of CD22 Offers Potential to Enhance CD22 Targeted Therapies, Including CAR-T cell therapy
Company Also Announces Completion of Safety Evaluation of Confirmatory, Phase 2, Placebo-Controlled Trial Evaluating Bryostatin-1 in Moderate to Severe Alzheimer's Disease
PR Newswire
NEW YORK, Feb. 4, 2019